FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to psychiatry, and can be used for assessing severity of a current depressive episode in patients with affective disorders, comorbid with personality disorders. Combined diagnostic criteria of severity of depressive episode and personality disorders are applied in accordance with ICD-10, as well as to SIGH-SAD scale before antidepressant therapy. Scale for assessing an intensity of psychic tension in accordance with Shihan scale, of depression in accordance with Beck's self-estimation scale, of suicidal behavior risk in accordance with questionnaire SBQ-R and of personality disorder signs in accordance with SAPAS. If the total score, which takes into account parameters of all used psychometric scales before antidepressant therapy, is more than 108, current depressive episode is estimated as severe.
EFFECT: method enables higher accuracy and integrity of clinical assessing severity of current depressive episode in case of comorbidity of affective and personality disorders, that enables more accurate determining a prognosis and further complex treatment and rehabilitation, as well as preventive programs in specific clinical cases due to usage of significant diagnostic criteria.
1 cl, 1 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF COMORBID ANXIOUS DISORDER IN PATIENTS WITH RECURRENT DEPRESSIVE DISORDER | 2017 |
|
RU2644636C1 |
ANTIDEPRESSIVE THERAPY | 2008 |
|
RU2379035C1 |
METHOD FOR ASSESSING SEVERITY OF CURRENT DEPRESSIVE EPISODE IN PATIENTS WITH RECURRENT DEPRESSIVE DISORDER | 2013 |
|
RU2540491C1 |
METHOD FOR ASSESSING THE RISK OF SUICIDAL BEHAVIOR OF PATIENTS WITH BIPOLAR AFFECTIVE DISORDER | 2019 |
|
RU2726470C1 |
METHOD OF TREATMENT OF DUODENUM ULCER DISEASE COMPLICATED BY COMORBID ANXIOUS DEPRESSION DISORDERS | 2007 |
|
RU2357729C2 |
METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
METHOD OF DIAGNOSING BORDERLINE PERSONALITY DISORDER | 2014 |
|
RU2564752C1 |
MEDICINAL AGENT, A PHARMACEUTICAL COMPOSITION, AN ACTIVE INGREDIENT OF THE PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING ANXIETY AND DEPRESSION IN THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2018 |
|
RU2702128C1 |
METHOD FOR DIAGNOSING AFFECTIVE DISORDER IN PATIENTS WITH ALCOHOL DEPENDENCE ACCORDING TO ELECTROENCEPHALOGRAPHIC STUDIES | 2023 |
|
RU2813702C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN DEPRESSIVE EPISODE | 2013 |
|
RU2530635C1 |
Authors
Dates
2016-10-20—Published
2015-07-20—Filed